Johnson & Johnson buy Jomaine
Start price
16.02.25
/
50%
€148.86
Target price
16.02.26
€155.00
Performance (%)
9.38%
End price
17.10.25
€162.82
Summary
This prediction ended on 17.10.25 with a price of €162.82. The BUY prediction by Jomaine finished with a performance of 9.38%. A total of €1.19 was paid as dividends for this prediction. Jomaine has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Johnson & Johnson | 4.004% | 4.004% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |